GGRUX
Price
$13.06
Change
-$0.04 (-0.31%)
Updated
Sep 20 closing price
RGEBX
Price
$73.82
Change
-$0.14 (-0.19%)
Updated
Sep 20 closing price
Ad is loading...

GGRUX vs RGEBX

Header iconGGRUX vs RGEBX Comparison
Open Charts GGRUX vs RGEBXBanner chart's image
Goldman Sachs Strategic Growth R6
Price$13.06
Change-$0.04 (-0.31%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R2E
Price$73.82
Change-$0.14 (-0.19%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GGRUX vs RGEBX Comparison Chart
Loading...
VS
GGRUX vs. RGEBX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGRUX is a Buy and RGEBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 290B vs. GGRUX (190M). RGEBX pays higher dividends than GGRUX: RGEBX (0.16) vs GGRUX (0.00). GGRUX was incepted earlier than RGEBX: GGRUX (9 years) vs RGEBX (10 years). GGRUX is a more actively managed with annual turnover of: 33.00 vs. RGEBX (31.00). RGEBX has a lower initial minimum investment than GGRUX: RGEBX (250) vs GGRUX (5000000). GGRUX annual gain was more profitable for investors over the last year : 30.61 vs. RGEBX (22.86). RGEBX return over 5 years is better than : 47.60 vs. GGRUX (25.06).
GGRUXRGEBXGGRUX / RGEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years10 years-
Gain YTD20.51518.896109%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets190M290B0%
Annual Yield % from dividends0.000.16-
Returns for 1 year30.6122.86134%
Returns for 3 years-6.43-4.80134%
Returns for 5 years25.0647.6053%
Returns for 10 yearsN/A56.25-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BOX32.990.15
+0.46%
BOX
EXR180.410.32
+0.18%
Extra Space Storage
PRM12.50-0.16
-1.26%
Perimeter Solutions SA
ADAP1.00-0.01
-1.38%
Adaptimmune Therapeutics plc
TRT5.34-0.10
-1.84%
Trio-Tech International